Lipid peroxyl and alkoxyl radicals (LOO•/LO•)

Lipid peroxyl (LOO•) and alkoxyl (LO•) radicals are highly reactive, oxygen-centered intermediates generated during the process of lipid peroxidation, specifically the autoxidation of polyunsaturated fatty acids (PUFAs) in biological membranes (Source: PubMed, PMID: 28853155). These radicals are the primary drivers of the propagation phase of oxidative damage, where they abstract hydrogen atoms from neighboring lipid molecules, leading to a chain reaction that compromises membrane integrity and cellular function (Source: NIH, StatPearls). They play a critical role in the execution of ferroptosis, a specialized form of regulated cell death characterized by iron-dependent lipid peroxide accumulation, which is linked to neurodegeneration, organ injury, and cancer (Source: Nature, DOI: 10.1038/s41586-020-2366-y). Furthermore, these radicals contribute to the pathogenesis of atherosclerosis by promoting the oxidative modification of low-density lipoproteins (LDL) (Source: PubChem). Pharmacological targeting of these species is achieved through "chain-breaking" antioxidants, such as alpha-tocopherol (Vitamin E) or small-molecule inhibitors like Ferrostatin-1, which neutralize the radicals to halt the peroxidative cascade (Source: PubMed, PMID: 22579052). Clinical assessment of their activity typically involves measuring stable end-products like malondialdehyde (MDA) or F2-isoprostanes (Source: Wikipedia). Therapeutic challenges include the need for high lipophilicity to ensure the drug reaches the lipid bilayer where these radicals reside. Additionally, non-specific scavenging can sometimes interfere with beneficial redox signaling pathways.

Other names

Lipid peroxyl radicalLipid alkoxyl radicalLipid-derived free radicalsLipid peroxidation intermediates

Chain-breaking antioxidant activity through radical scavenging and hydrogen atom donation.